SNDX CIK: 1395937

Syndax Pharmaceuticals Inc

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.45
FY22:
0.49
FY23:
0.58
FY24:
0.60
FY25:
0.53
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.01
FY23:
0.03
FY24:
0.12
FY25:
0.00
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.45
FY22:
0.50
FY23:
0.61
FY24:
0.72
FY25:
0.53

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.03
FY23:
0.06
FY24:
0.10
FY25:
0.12
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.00
FY23:
0.00
FY24:
0.33
FY25:
0.34
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.41
FY22:
0.47
FY23:
0.55
FY24:
0.29
FY25:
0.06
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.45
FY22:
0.50
FY23:
0.61
FY24:
0.72
FY25:
0.53

All amounts in billions USD Data source:SEC EDGAR